Influence of patient characteristics on efficacy and safety of anti-amyloid monoclonal antibodies in Alzheimer's disease: A systematic review and meta-analysis.

Evidence span

Influence of patient characteristics on efficacy and safety of anti-amyloid monoclonal antibodies in Alzheimer's disease: A systematic review and meta-analysis.

From Shim GH et al. 2026, Ageing research reviews

Method & conditions

Evidence type

experimental

Method

manual state transition; control details require source inspection

Species

Homo sapiens

Conditions

Humans; Alzheimer Disease; Antibodies, Monoclonal; Treatment Outcome; Amyloid beta-Peptides — Ageing research reviews 2026

Replicated

not yet

Confidence basis

operator-supplied frontier prior; review required